Regent Peak Wealth Advisors LLC Organogenesis Holdings Inc. Transaction History
Regent Peak Wealth Advisors LLC
- $507 Million
- Q4 2025
A detailed history of Regent Peak Wealth Advisors LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Regent Peak Wealth Advisors LLC holds 14,165 shares of ORGO stock, worth $64,167. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,165
Previous 12,060
17.45%
Holding current value
$64,167
Previous $54,000
18.52%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ORGO
# of Institutions
127Shares Held
70.2MCall Options Held
39.7KPut Options Held
0-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Assenagon Asset Management S.A.5.54MShares$25.1 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...